Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 5, 2001, Pages 1505-1510

  Seifert, K ^a   Duchene M ^a   Wernsdorfer, W H ^a   Kollaritsch, H ^a   Scheiner, O ^a   Wiedermann, G ^a   Hottkowitz, T ^a   Eibl, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; MILTEFOSINE; NITROIMIDAZOLE DERIVATIVE; PHOSPHORYLCHOLINE;

ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG EFFECT; DRUG TOLERABILITY; DYSENTERY; ENTAMOEBA HISTOLYTICA; INTESTINE PARASITE; LIVER ABSCESS; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; STRAIN DIFFERENCE; TISSUE INJURY; TROPHOZOITE;

ANIMALS; ANTIPROTOZOAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HUMANS; INTESTINAL DISEASES; LIPOSOMES; PHOSPHORYLCHOLINE;

EID: 0035035188     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.5.1505-1510.2001     Document Type: Article

References (34)

1. New cytostatics with experimentally different toxic profiles
2. New cytostatics - More activity and less toxicity
3. The activities of four anti-cancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei
4. A new medium for the axenic cultivation of Entamoeba histolytica and other entamoeba
5. Phospholipid synthesis: Oxazaphospholanes and dioxaphospholanes as intermediates
6. Synthesis of hexadecylphosphocholine (miltefosine)
7. Hexadecylphosphocholine: A new and selective antitumor drug
8. Medical application of synthetic phospholipids as liposomes and drugs
9. Metabolism of ether phospholipids and analogs in neoplastic cells
10. Metronidazole
11. Hexadecylphosphocholine inhibits translocation of CTP: Choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells
12. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)
13. A simple method of inducing amoebic liver abscess in hamsters
14. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
15. Morphological changes of adherent and nonadherent cells by treatment with hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine observed by scanning electron microscopy
16. Pharmacokinetic behaviour and antineoplastic activity of liposomal hexadecylphosphocholine
17. Intravenous treatment of Leishmania donovani infected mice with liposomal hexadecylphosphocholine
18. Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies
19. Hexadecylphosphocholine: Oral treatment of visceral leishmaniasis in mice
20. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials
21. A simplified method for evaluating dose-effect experiments
22. Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkylphospholipid analogues
23. Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment
24. Involvement of superoxide dismutase and pyruvate: Ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica
25. Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi
26. The reliability of Entamoeba histolytica zymodemes in clinical diagnosis
27. Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo
28. Resistance to the nitroheterocyclic drugs
29. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity
30. Hexadecylphosphocholine: Determination of serum concentrations in rats
31. Problems in recognition and diagnosis of amebiasis: Estimation of the global magnitude of morbidity and mortality
32. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase
33. The evaluation of in vitro tests for the assessment of drug response in Plasmodium falciparum